Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1213021.RAYzNibYPHepAe1NhURYVjsEnA_YPl_itj1EsC73C28oE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1213021.RAYzNibYPHepAe1NhURYVjsEnA_YPl_itj1EsC73C28oE130_assertion type Assertion NP1213021.RAYzNibYPHepAe1NhURYVjsEnA_YPl_itj1EsC73C28oE130_head.
- NP1213021.RAYzNibYPHepAe1NhURYVjsEnA_YPl_itj1EsC73C28oE130_assertion description "[rhIL-24 circumvented the drug-resistance of MCF-7/ADM cells via activation of the transcription factor Stat 3. rhIl24 has potential to act as a P-gp inhibitor to reverse Adriamycin resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1213021.RAYzNibYPHepAe1NhURYVjsEnA_YPl_itj1EsC73C28oE130_provenance.
- NP1213021.RAYzNibYPHepAe1NhURYVjsEnA_YPl_itj1EsC73C28oE130_assertion evidence source_evidence_literature NP1213021.RAYzNibYPHepAe1NhURYVjsEnA_YPl_itj1EsC73C28oE130_provenance.
- NP1213021.RAYzNibYPHepAe1NhURYVjsEnA_YPl_itj1EsC73C28oE130_assertion SIO_000772 25150001 NP1213021.RAYzNibYPHepAe1NhURYVjsEnA_YPl_itj1EsC73C28oE130_provenance.
- NP1213021.RAYzNibYPHepAe1NhURYVjsEnA_YPl_itj1EsC73C28oE130_assertion wasDerivedFrom befree-2016 NP1213021.RAYzNibYPHepAe1NhURYVjsEnA_YPl_itj1EsC73C28oE130_provenance.
- NP1213021.RAYzNibYPHepAe1NhURYVjsEnA_YPl_itj1EsC73C28oE130_assertion wasGeneratedBy ECO_0000203 NP1213021.RAYzNibYPHepAe1NhURYVjsEnA_YPl_itj1EsC73C28oE130_provenance.